pharmacology

There are currently no FDA-approved drugs to treat vitiligo, an autoimmune disease that kills skin pigment cells. But a phase III study of a drug used to treat atopic dermatitis may be the first to get the FDA seal of approval.

COVID-19 researchers focus their studies on antibodies targeting exposed parts of SARS-CoV-2, but in a new study, a group of researchers showed that antibodies targeting proteins inside the virus are just as important for a robust immune response.

Some scientists use cancer patients as libraries for discovering novel immunotherapies.

An obesity medicine clinician researcher propels a growing movement to normalize obesity as a disease that requires long-term treatment.

Age-related macular degeneration is the most common cause of vision loss in adults over age 50, but there are few treatments available. Researchers are now developing promising stem cell therapies to treat the disease.

Membraneless droplet like organelles known as condensates are changing the way some scientists approach drug discovery.

The company plans to develop more specialized, antibody-based GPCR drugs to treat a myriad of diseases. They recruited a leader in overseeing successful clinical trials to get the job done.

LIVE October 12th, 2021 at 11:30 AM ET

Bill Thelin will discuss how intestine-on-a chip technology reliably models gastrointestinal disease and assists researchers in screening for safe, effective therapeutic candidates.

LIVE May 25th, 2021 at 10:30 AM ET
This webinar will discuss new drug delivery approaches to overcoming the blood-brain barrier.

BetterLife enters research agreement with UCSD for TD-0148A behavioral pharmacology studies